5(S)urbatovic' M,Jovanovic' K,Radakovic' S,et al.Pathophysiological aspects of severe acute pancreatitis-associated lung injury[J] .Srpski Arhivza Celokupno Lekarstvo,2005,133 (1-2):76-81.
6Quartilho A,Mata HP,Ibrahim MM,et al.Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors[J] .Anesthesiology,2003,99 (4):955-960.
7Després JP,Golay A,Sj(o)str(o)m L.Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia[J] .New England Journal of Medicine,2005,353 (20):2121-2134.
8Mavromoustakos T,Yang D,Theodoropoulou E,et al.Studies of the conformational properties of the cannabimimetic aminoalkylindole pravadoline using NMR and molecular modeling[J] .European Journal of Medicinal Chemistry,1995,30 (3):227-234.
9Petrocellis LD,Cascio MG,Marzo VD.The endocannabinoid system:a general view and latest additions[J] .British Journal of Pharmacology,2004,141 (5):765-774.
10Atwood BK,Straiker A,Mackie K.CB2:Therapeutic target-in-waiting[J] .Progress in Neuro-Psychopharmacology and Biological Psychiatry,2012,38(1):16-20.
